LPL Financial
NVIV

LPL Financial’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

LPL Financial’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1
Closed -$11K – 3345
2018
Q1 		$11K Hold
1
– – ﹤0.01% 3159
2017
Q4 		$14K Hold
1
– – ﹤0.01% 3007
2017
Q3 		$33K Hold
1
– – ﹤0.01% 2832
2017
Q2 		$64K Hold
1
– – ﹤0.01% 2741
2017
Q1 		$92K Hold
1
– – ﹤0.01% 2622
2016
Q4 		$109K Hold
1
– – ﹤0.01% 2581
2016
Q3 		$133K Sell
1
-1
-50% -$125K ﹤0.01% 2491
2016
Q2 		$186K Sell
2
-1
-33% -$118K ﹤0.01% 2406
2016
Q1 		$311K Hold
3
– – ﹤0.01% 2482
2015
Q4 		$381K Buy
3
+2
+200% +$297K ﹤0.01% 2367
2015
Q3 		$203K Hold
1
– – ﹤0.01% 2501
2015
Q2 		$297K Buy
+1
New +$264K ﹤0.01% 2311

Other funds holding NVIV

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LPL Financial's NVIV Position: Q2 2018 in Review

LPL Financial sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q2 2018, closing a stake of 1 share — an estimated $11K sold.

LPL Financial first reported a position in NVIV in Q2 2015 and held it in 12 quarters. The position peaked at $381K in Q4 2015. 17 funds tracked by Wall St. Rank hold NVIV as of Q2 2018.

  • LPL Financial reported no remaining InVivo Therapeutics Holdings Corp position as of Q2 2018 after selling out during the quarter.
  • LPL Financial sold 1 InVivo Therapeutics Holdings Corp share in Q2 2018, an estimated $11K.
  • LPL Financial first reported a position in InVivo Therapeutics Holdings Corp in Q2 2015 and held it in 12 quarters.
  • LPL Financial's InVivo Therapeutics Holdings Corp position peaked at $381K in Q4 2015.
  • 17 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q2 2018.

Based on LPL Financial's 13F filing for Q2 2018, filed 14 Aug 2018.